bioRxiv Science⌕ Search

Biology subjects

Pell, M. E.

Publications and source records attributed to Pell, M. E..

2 recordsLinked to original sources

Negative feedback of cyclic di-GMP levels optimizes switching between sessile and motile lifestyles in Vibrio cholerae

The signaling molecule cyclic di-GMP (c-di-GMP) controls the switch between bacterial motility and biofilm production, and fluctuations in cellular levels of c-di-GMP have been implicated in Vibrio cholerae pathogenesis. Intracellular concentrations of c-di-GMP are controlled by the interplay of diguanylate cyclase (DGC) enzymes, which synthesize c-di-GMP to promote biofilms, and phosphodiesterase (PDE) enzymes, which hydrolyze c-di-GMP to drive motility. To track the complete regulatory logic of how V. cholerae responds to changing c-di-GMP levels, we followed a time course of overexpression of either the V. campbellii diguanylate cyclase QrgB or a variant of QrgB lacking catalytic activity (QrgB*). We find that QrgB increases c-di-GMP levels relative to QrgB* for 30 minutes after overexpression, but the effect of QrgB on c-di-GMP levels plateaus at 30 minutes, indicating tight adaptive control of c-di-GMP levels. In contrast, loss of VpsR, a master regulator activating biofilm formation upon binding to c-di-GMP, leads to higher baseline levels of c-di-GMP and continuously increasing c-di-GMP through 60 minutes after QrgB induction, revealing the existence of a negative feedback loop on c-di-GMP levels operating through VpsR. Through a combination of RNA polymerase ChIP-seq, RNA-seq, and genetic approaches, we show that transcription of a gene encoding a PDE, cdgC, is activated by VpsR at high c-di-GMP concentrations, mediating this negative feedback on c-di-GMP levels. Further, although cells lacking cdgC exhibit enhanced biofilm formation, these mutants are outcompeted by wild type V. cholerae in colonization assays that reward a combination of attachment, dispersal, and motility behaviors. These results underscore the importance of negative feedback regulation of c-di-GMP to maintain appropriate homeostatic levels for efficient transitioning between biofilm formation and motility, both of which are necessary over the course of the V. cholerae infection cycle.

microbiology↗

Intrapartum antibiotic prophylaxis selects for mutators in group B streptococci among persistently colonized patients

Through vaginal colonization, GBS causes severe outcomes including neonatal sepsis and meningitis. Although intrapartum antibiotic prophylaxis (IAP) has reduced neonatal disease rates, persistent GBS colonization has been observed in patients following prophylaxis. To determine whether IAP selects for genomic signatures that enhance GBS survival and persistence, a pangenome analysis was performed on 97 isolates from 58 participants before (prenatal) and after (postpartum) IAP/childbirth. Thirty-one of the 34 paired strains from participants with persistent colonization clustered together in the core gene phylogeny, suggesting that the strains recovered at the postpartum sampling were highly similar to those recovered at the prenatal visit. A core-gene mutation analysis identified mutations in 74% (n=23) of the 31 postpartum genomes when compared to the prenatal strains of the same multilocus sequence type recovered from the same individuals. Several strains had acquired mutations in the same colonization-associated genes, though two postpartum strains accounted for most of the mutations. These two outliers were classified as mutators based on high mutation rates and mutations within DNA repair system genes. Increased biofilm production was observed in half of the postpartum strains relative to the prenatal strains, which is supported by the presence of point mutations in genes associated with adherence. Together, these findings suggest that antibiotics may impose a selective pressure on GBS that selects for mutations and phenotypes that promote adaptation and survival in vivo. Enhanced survival in the genitourinary tract can lead to persistent colonization, increasing the likelihood of invasive disease in subsequent pregnancies and in newborns following IAP.

evolutionary biology↗